Additionally, since early signs of diabetic nephropathy were observed, future studies should assess cardiovascular parameters, investigate the underlying molecular mechanisms, consider sex-specific responses, and evaluate whether combining CR-TRF with insulin therapy or antidiabetic agents could enhance therapeutic outcomes in T1D. This evidence concerns the gene INS and type 1 diabetes mellitus.